Press release

January 2019

Scilex Announces Addition of ZTlido® to Express Scripts National Formularies

January 14, 2019

SAN DIEGO, Jan. 14, 2019 (GLOBE NEWSWIRE) — Scilex Pharmaceuticals Inc. (SCILEX), a subsidiary of Sorrento Therapeutics, Inc. (NASDAQ: SRNE), today announced that Express Scripts has added ZTlido® (lidocaine topical system) 1.8% to its commercial national formularies representing nearly 30 million lives.  ZTLIDO is indicated for relief of pain associated with postherpetic neuralgia (PHN), also … Continue reading Scilex Announces Addition of ZTlido® to Express Scripts National Formularies

Scilex Announces ZTlido® Insurance Coverage for ~100 Million Insured Lives(1)

SAN DIEGO, Jan. 14, 2019 (GLOBE NEWSWIRE) — Scilex Pharmaceuticals Inc. (SCILEX), a subsidiary of Sorrento Therapeutics, Inc. (NASDAQ: SRNE), today announced that ZTlido® (lidocaine topical system) 1.8% (ZTLIDO) is covered by nearly 100M U.S. insured lives1.  ZTLIDO is indicated for relief of pain associated with postherpetic neuralgia (PHN), also referred to as post-shingles pain. … Continue reading Scilex Announces ZTlido® Insurance Coverage for ~100 Million Insured Lives(1)
X

Share This Page

XS SM MD LG XL